CKD
Potassium-Sparing Agents Put a Rise in RAASis
Newer agents are reenergizing the treatment of hyperkalemia, a serious condition characterized by elevated serum ...
JUNE 10, 2021
FDA Grants New Indication to Farxiga to Prevent Progression of CKD
Dapagliflozin already has an indication for improving glycemic control and reducing the risk for hospitalization ...
MAY 4, 2021
Load more